Abstract:Due to the complex and heterogeneous etiology of autism spectrum disorder (ASD), identification of convergent pathways and/or common molecular endpoints in the pathophysiological processes of ASD development are highly needed in order to facilitate treatment approaches targeted at the core symptoms. We recently reported on decreased expression of the Ca2+-binding protein parvalbumin (PV) in three well-characterized ASD mouse models, Shank1-/-, Shank3B-/- and in utero VPA-exposed mice. Moreover, PV-deficient mice (PV+/- and PV-/-) were found to show behavioral impairments and neuroanatomical changes closely resembling those frequently found in human ASD individuals. Here, we combined a stereology-based approach with molecular biology methods to assess changes in the subpopulation of PV-expressing (Pvalb) interneurons in the recently characterized contactin-associated protein-like 2 (Cntnap2-/-) knockout mouse model of ASD. The CNTNAP2 gene codes for a synaptic cell adhesion molecule involved in neurodevelopmental processes; mutations affecting the human CNTNAP2 locus are associated with human ASD core symptoms, in particular speech and language problems. We demonstrate that in Cntnap2-/- mice, no loss of Pvalb neurons is evident in ASD-associated brain regions including the striatum, somatosensory cortex (SSC) and medial prefrontal cortex (mPFC), shown by the unaltered number of Pvalb neurons ensheathed by VVA-positive perineuronal nets. However, the number of PV-immunoreactive (PV+) neurons and also PV protein levels were decreased in the striatum of Cntnap2-/- mice indicating that PV expression levels in some striatal Pvalb neurons dropped below the detection limit, yet without a loss of Pvalb neurons. No changes in PV+ neuron numbers were detected in the cortical regions investigated and also cortical PV expression levels were unaltered. Considering that Cntnap2 shows high expression levels in the striatum during human and mouse embryonic development and that the cortico-striato-thalamic circuitry is important for speech and language development, alterations in striatal PV expression and associated (homeostatic) adaptations are likely to play an important role in Cntnap2-/- mice and, assumingly, in human ASD patients with known Cntnap2 mutations.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is the dysfunction of specific neuronal subpopulations in Autism Spectrum Disorder (ASD), especially the changes of parvalbumin (PV) - expressing interneurons in the Cntnap2 gene - knockout mouse model. Specifically, the research focuses on the following points: 1. **Changes in PV expression**: The study aims to evaluate the changes in PV expression in the Cntnap2 gene - knockout mouse model, especially in brain regions such as the striatum, somatosensory cortex (SSC), and medial prefrontal cortex (mPFC) that are closely related to ASD pathology. 2. **Number of PV - positive neurons**: Through stereological methods and molecular biology techniques, researchers attempt to determine whether the number of PV - positive neurons has changed and whether this change is related to the decrease in PV expression levels. 3. **Exploration of molecular mechanisms**: The study also explores the molecular mechanisms behind the changes in PV expression, including changes at the transcriptional and translational levels, as well as the expression of other related genes, such as GAD67, Kv3.1, Kv3.2, Kv9.3, and members of the HCN channel family. ### Research background Autism Spectrum Disorder is a complex neurodevelopmental disorder, and its etiology involves complex interactions of genetic, epigenetic, and environmental factors. Research has found that PV - positive interneurons are functionally impaired in multiple ASD mouse models, which may be a common molecular endpoint in different ASD models. The Cntnap2 gene encodes a synaptic cell - adhesion molecule, and its mutations are related to the core symptoms of human ASD, especially language and communication disorders. ### Main findings 1. **Decrease in PV expression in the striatum**: - In the striatum of Cntnap2 gene - knockout mice, the number of PV - positive neurons is significantly reduced by approximately 20%, but the number of Vicia Villosa Agglutinin (VV A) - positive neurons has no change, indicating a decrease in PV expression level rather than neuronal loss. - Protein - level analysis shows that the PV protein level in the striatum of Cntnap2 gene - knockout mice also significantly decreases by approximately 22%. 2. **No change in PV expression in the cortex**: - In the somatosensory cortex and medial prefrontal cortex, neither the number of PV - positive neurons nor the PV expression level has changed. - The mRNA levels of related genes such as GAD67, Kv3.1, Kv3.2, and Kv9.3 also have no significant differences. 3. **Decrease in HCN4 expression**: - In the striatum, the mRNA level of HCN4 in Cntnap2 gene - knockout mice is significantly decreased by approximately 40%. ### Conclusion This study confirms the down - regulation of PV expression in the striatum of Cntnap2 gene - knockout mice, while the PV expression in the cortex remains unchanged. These results support that the down - regulation of PV expression may be a common molecular endpoint in different ASD models and provide new clues for further understanding the pathological mechanisms of ASD.

Dysregulation of Parvalbumin Expression in the Cntnap2−/− Mouse Model of Autism Spectrum Disorder

Deletions of Cacna2d3 in parvalbumin-expressing neurons leads to autistic-like phenotypes in mice

Lack of parvalbumin in mice leads to behavioral deficits relevant to all human autism core symptoms and related neural morphofunctional abnormalities

Altered Relationship Between Parvalbumin and Perineuronal Nets in an Autism Model

Dysregulation of parvalbumin expression and neurotransmitter imbalance in the auditory cortex of the BTBR mouse model of autism spectrum disorder

The Parvalbumin Hypothesis of Autism Spectrum Disorder

Reduced prefrontal synaptic connectivity and disturbed oscillatory population dynamics in the CNTNAP2 model of autism

Late onset and regional heterogeneity of synaptic deficits in cortical PV interneurons of Shank3B−/− mice

Developmental deficits of MGE-derived interneurons in the Cntnap2 knockout mouse model of autism spectrum disorder

CNTNAP2 intracellular domain (CICD) generated by γ-secretase cleavage improves autism-related behaviors

Transient CSF1R inhibition ameliorates behavioral deficits in Cntnap2 knockout and valproic acid-exposed mouse models of autism

Impaired emotion recognition in Cntnap2-deficient mice is associated with hyper-synchronous prefrontal cortex neuronal activity

Gestational VPA exposure reduces the density of juxtapositions between TH+ axons and calretinin or calbindin expressing cells in the ventrobasal forebrain of neonatal mice

Contactin-associated protein-like 2 (CNTNAP2) mutations impair the essential α-secretase cleavages, leading to autism-like phenotypes

Properties of the Caudal Pontine Reticular Nucleus Neurons Determine the Acoustic Startle Response in Cntnap2 KO Rats

Aberrant Development and Synaptic Transmission of Cerebellar Cortex in a VPA Induced Mouse Autism Model

Investigating behavioral phenotypes related to autism spectrum disorder in a gene-environment interaction model of Cntnap2 deficiency and Poly I:C maternal immune activation

Deletion of CTNNB1 in inhibitory circuitry contributes to autism-associated behavioral defects

NMDA receptor hypofunction underlies deficits in parvalbumin interneurons and social behavior in neuroligin 3 R451C knockin mice

Reduced excitatory activity in the developing mPFC mediates a PVH-to-PVL transition and impaired social cognition in autism spectrum disorders

Cntnap2-dependent molecular networks in autism spectrum disorder revealed through an integrative multi-omics analysis